Januvia 100mg Tab

Manufacturer
Merck Sharp & Dohme

Registraction Number
MAL20071664ACRZ

 

Content

• Each tablet contains 100 mg of sitagliptin phosphate monohydrate, the active ingredient.

• Januvia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
• It can be used alone or in combination with other antidiabetic medications such as metformin, sulfonylureas, or insulin when these alone do not provide adequate control.

• Recommended dose: 100 mg once daily.
• Januvia can be taken with or without food.
• Dosage adjustments are necessary for patients with renal impairment:
  • For moderate renal impairment (eGFR ≥30 to <45 mL/min/1.73 m²): 50 mg once daily.
  • For severe renal impairment (eGFR ≥15 to <30 mL/min/1.73 m²) or end-stage renal disease (eGFR <15 mL/min/1.73 m²) requiring hemodialysis or peritoneal dialysis: 25 mg once daily.